| Summary: | Abstract Ocular immune‐related diseases, represent a spectrum of conditions driven by immune system dysregulation, include but not limit to uveitis, diabetic retinopathy, age‐related macular degeneration, Graves’ ophthalmopathy, etc. The molecular and cellular mechanisms underlying these diseases are typically dysfunctioned immune responses targeting ocular tissues, resulting in inflammation and tissue damage. Recent advances have further elucidated the pivotal role of different immune responses in the development, progression, as well as management of various ocular immune diseases. However, there is currently a relative lack of connection between the cellular mechanisms and treatments of several immune‐related ocular diseases. In this review, we discuss recent findings related to the immunopathogenesis of above‐mentioned diseases. In particular, we summarize the different types of immune cells, inflammatory mediators, and associated signaling pathways that are involved in the pathophysiology of above‐mentioned ophthalmopathies. Furthermore, we also discuss the future directions of utilizing anti‐inflammatory regime in the management of these diseases. This will facilitate a better understanding of the pathogenesis of immune‐related ocular diseases and provide new insights for future treatment approaches.
|
|---|
